PAM
ABUS icon

Panagora Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Panagora Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-350
Closed -$1K – 2497
2019
Q4 		$1K Sell
350
-1,911
-85% -$3.09K ﹤0.01% 2388
2019
Q3 		$3K Sell
2,261
-30,323
-93% -$52.3K ﹤0.01% 2343
2019
Q2 		$68K Sell
32,584
-13,340
-29% -$34.1K ﹤0.01% 2040
2019
Q1 		$164K Sell
45,924
-25,975
-36% -$99.7K ﹤0.01% 1764
2018
Q4 		$275K Buy
+71,899
New +$354K ﹤0.01% 1514

Other funds holding ABUS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Panagora Asset Management's ABUS Position: Q1 2020 in Review

Panagora Asset Management sold out of Arbutus Biopharma (ABUS) in Q1 2020, closing a stake of 350 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in ABUS in Q4 2018 and held it in 5 quarters. The position peaked at $275K in Q4 2018. 48 funds tracked by Wall St. Rank hold ABUS as of Q1 2020.

  • Panagora Asset Management reported no remaining Arbutus Biopharma position as of Q1 2020 after selling out during the quarter.
  • Panagora Asset Management sold 350 Arbutus Biopharma shares in Q1 2020, an estimated $1K.
  • Panagora Asset Management first reported a position in Arbutus Biopharma in Q4 2018 and held it in 5 quarters.
  • Panagora Asset Management's Arbutus Biopharma position peaked at $275K in Q4 2018.
  • 48 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2020.

Based on Panagora Asset Management's 13F filing for Q1 2020, filed 14 May 2020.